Elsa Lilienberg
Uppsala, C, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Pharmacokinetics of Total and Unbound Paclitaxel After Administration of Paclitaxel Micellar or Nab-Paclitaxel: An Open, Randomized, Cross-Over, Explorative Study in Breast Cancer Patients.
Journal: Advances in therapy
Published: June 26, 2019
Maximum Tolerated Dose and Pharmacokinetics of Paclitaxel Micellar in Patients with Recurrent Malignant Solid Tumours: A Dose-Escalation Study.
Journal: Advances in therapy
Published: January 18, 2019
Reply to "Comment on 'In Vivo Drug Delivery Performance of Lipiodol-Based Emulsion or Drug-Eluting Beads in Patients with Hepatocellular Carcinoma'".
Journal: Molecular pharmaceutics
Published: November 30, 2017
A Model-Based Approach To Assessing the Importance of Intracellular Binding Sites in Doxorubicin Disposition.
Journal: Molecular pharmaceutics
Published: February 10, 2017
In Vivo Drug Delivery Performance of Lipiodol-Based Emulsion or Drug-Eluting Beads in Patients with Hepatocellular Carcinoma.
Journal: Molecular pharmaceutics
Published: December 21, 2016
Lipiodol does not affect the tissue distribution of intravenous doxorubicin infusion in pigs.
Journal: The Journal of pharmacy and pharmacology
Published: May 21, 2016
The effects of lipiodol and cyclosporin A on the hepatobiliary disposition of doxorubicin in pigs.
Journal: Molecular pharmaceutics
Published: February 25, 2014
Investigation of hepatobiliary disposition of doxorubicin following intrahepatic delivery of different dosage forms.
Journal: Molecular pharmaceutics
Published: November 01, 2013
Showing 1-9 of 9
Last Updated: 09/26/2026